Prescription drugs too costly? Changing your health plan could save money

Patients insured by Medicare Part D can use a free online tool to compare plans and reduce out-of-pocket prescription drug expenses

5:00 AM

Author | Nicole Fawcett

The Medicare Part D Plan Finder can help reduce out-of-pocket prescription drug expenses. Credit: Michigan Medicine

Editor’s note: Open enrollment runs Oct. 15 - Dec. 7

Every year, health plans offer open enrollment – a time to reassess your benefits and select new options.

But is it worth the hassle to change plans?

For people with expensive prescription drugs, switching plans could save them thousands of dollars in copays.

And a simple tool can help people easily compare out-of-pockets expenses for anyone with a Medicare Part D prescription plan.

“Understanding how out-of-pocket spending varies for prescription drugs is important for patients, physicians and policymakers. With this awareness, patients can pick the best Medicare Part D plan to reduce out-of-pocket drug costs and mitigate financial toxicity of health care,” said Kristian Stensland, M.D., M.S., M.P.H., assistant professor of urology at Michigan Medicine.

Stensland is leading a team of researchers at the University of Michigan Health Rogel Cancer Center and the University of Michigan Institute for Healthcare Policy and Innovation who want to make people more broadly aware of Part D open enrollment and specifically the free Medicare Plan Finder tool that makes comparing costs easy.

The plan finder, which is funded by the United States Centers for Medicare and Medicaid Services, is available online at medicare.gov/plan-compare.

Patients enter their zip code and prescription drugs; the finder displays estimated annual out-of-pocket costs for local retail and mail order pharmacies.

SEE ALSO: Free online tool helps prostate cancer patients save on out-of-pocket drug costs

Medicare’s open enrollment runs from Oct. 15 - Dec. 7 every year, during which time people can switch plans. More than 49 million Americans are enrolled in Medicare Part D, and some patients have up to 50 different plans to choose from.

Despite significant cost differences, fewer than 30% of patients report comparing drug plan pricing.

In a recent study that used the plan finder to evaluate the cost of two drugs commonly prescribed for prostate cancer, researchers found that patients could potentially save $9,000 a year by comparing plans.

“Patients with Medicare Part D have dozens of different drug plans available to choose from, but most patients unfortunately are not aware of this. If they compare estimated costs, they could save thousands of dollars each year in drug costs,” said Benjamin Pockros, M.D., M.B.A., a urology resident at Michigan Medicine.

“This could make a huge impact for patients with limited resources.”

The researchers created a video to promote using the plan finder during open enrollment, part of Michigan Medicine’s commitment to helping everyone find affordable health care.

In addition to the plan finder, many hospitals have financial counselors who can help with comparing health care plans.

IHPI will host a webinar on Oct. 27 about navigating open enrollment. It’s part of the institute’s Healthy Aging Series. Learn more and register.

Funding for this work is from the University of Michigan’s Rogel Cancer Center and Institute for Healthcare Policy and Innovation. In addition to Stensland and Pockros, IHPI member Chad Ellimootil, M.D., M.S., and Rogel and IHPI member Megan Caram, M.D., are also part of the project.


More Articles About: Health Care Delivery, Policy and Economics Hospitals & Centers Community Health Cancer (Oncology)
Health Lab word mark overlaying blue cells
Health Lab

Explore a variety of health care news & stories by visiting the Health Lab home page for more articles.

Media Contact Public Relations

Department of Communication at Michigan Medicine

[email protected]

734-764-2220

Stay Informed

Want top health & research news weekly? Sign up for Health Lab’s newsletters today!

Subscribe
Featured News & Stories man at table writing down in living room
Health Lab
Free online tool helps prostate cancer patients save on out-of-pocket drug costs
A free online tool could potentially save some prostate cancer patients more than $9,000 in out-of-pocket drug costs, a Michigan Medicine study finds.
three friends standing outside rogel cancer center building with big white ribbons
Health Lab
A lung cancer survivor shaping lung cancer advocacy
One woman's unexpected lung cancer diagnosis leads her to help many who aren't aware they're at risk of the disease.
On left, a young boy in a wheelchair has his doctor standing to his left and his parent is standing to his right in a show of support. On the right side of the image, the boy is now an adult and is wondering about the cost of his care and if his questions will be answered.
Health Lab
Changing the definition of cerebral palsy
Cerebral palsy is defined as a childhood disorder, which fails to recognize adults living with the condition and the lack of care they receive once they age out of pediatric clinics.
purple gloves close up holding piece
Health Lab
Recycled pacemakers function as well as new devices, international study suggests
Recycled pacemakers can function as well as new devices, a University of Michigan-led study suggests. These used and reconditioned devices have the potential to increase access to pacemaker therapy in low- and middle-income countries, where many patients cannot afford the treatment.
pigs sick and chickens in background with blue background and green cells floating around
Health Lab
Why the bird flu’s jump to pigs is concerning
A Michigan Medicine virologist speaks about the implications of H5N1 influenza, or bird flu, and whether a new pandemic could be on the horizon.
floating AI-type images in red and blues and yellow on blue background
Health Lab
Racial differences in medical testing could introduce bias to AI models
Black patients are less likely than white patients to receive certain medical tests that doctors use to diagnose severe disease, impacting artificial intelligence data. But researchers have found a way to correct the bias in these data sets.